SavedAdd your journal

Journals / Turkish Journal of Medical Sciences / 2014 / Cilt: 44 - Sayı: 3

Prevalence of blaIMP and blaVIM gene carriage in metallo-β lactamase-producing burn isolates of Pseudomonas aeruginosa in Tehran

Fereshteh EFTEKHAR
Fatemeh SALIMI
Pages
511–514
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was also a strong association between MBL gene carriage and AmpC β-lactamase production

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: To study the prevalence of blaVIM and blaIMP genes in metallo-β-lactamase (MBL) producing burn isolates of Pseudomonas aeruginosa in relation with AmpC and extended-spectrum β-lactamase (ESBL) production.
📊
Key Findings & Data:Antibiotic susceptibility was determined to 13 antibiotics including imipenem and meropenem by disk diffusion.
💡
Conclusion & Impact:There was also a strong association between MBL gene carriage and AmpC β-lactamase production
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: To study the prevalence of blaVIM and blaIMP genes in metallo-β-lactamase (MBL) producing burn isolates of Pseudomonas aeruginosa in relation with AmpC and extended-spectrum β-lactamase (ESBL) production. Materials and methods: Thirty-two carbapenem-resistant MBL-producing P. aeruginosa burn isolates from Shahid Motahari Burn Hospital in Tehran were employed. Antibiotic susceptibility was determined to 13 antibiotics including imipenem and meropenem by disk diffusion. AmpC and ESBL production was detected by the AmpC disk test and combined disk diffusion assay, respectively. blaIMP and blaVIM gene carriage was shown by polymerase chain reaction and type-specific primers. Results: AmpC production was observed in 81% and ESBL production was detected in 12.5% of the isolates. blaIMP carriage was observed in 56.25% and blaVIM gene in 46.8% of the isolates. Surprisingly, 43.5% of the isolates carried both blaIMP and blaVIM genes. Conclusion: We think that this is the first report on the cocarriage of blaIMP and blaVIM in P. aeruginosa. There was also a strong association between MBL gene carriage and AmpC β-lactamase production

🔖

Cite This Article

EFTEKHAR, F., SALIMI, F. (2022). Prevalence of blaIMP and blaVIM gene carriage in metallo-β lactamase-producing burn isolates of Pseudomonas aeruginosa in Tehran. Turkish Journal of Medical Sciences, Cilt: 44 - Sayı: 3, 511–514. https://ajindex.com/articles/611006

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Chakraborty D, Basu S, Das S. A study on infections caused by metallo-β-lactamase producing Gram negative bacteria in intensive care unit patients. Am J Infect Dis 2010; 6: 34–39
  2. Kouda S, Kuwahara R, Ohara M, Shigeta M, Fujiwara T, Komatsuzawa H, Usui T, Sugai M. First isolation of blaIMP-7 in a Pseudomonas aeruginosa in Japan. J Infect Chemother 2007; 13: 276–277
  3. Kohler T, Michea‐Hamzehpour M, Epp SF, Pechere JC. Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems. Antimicrob Agent Chemother 1999; 43: 424–427
  4. Livermore DM. Interplay of impermeability and chromosomal β-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob Agent Chemother 1992; 36: 2046– 2048
  5. Nordmann P, Poirel L. Emerging carbapenemases in Gramnegative aerobes. Clin Microbial Infect 2002; 8: 321–331
  6. Pitout JDD, Gregson DB, Poirel L, McClure JA, Le P, Church DL. Detection of Pseudomonas aeruginosa producing metallo- β-lactamases in a large centralized laboratory. J Clin Microbiol 2005; 43: 3129–3135
  7. Rossolini GM. Acquired metallo-β-lactamases: an increasing clinical threat. Clin Infect Dis 2005; 41: 1557–1558
  8. Castanheira M, Toleman MA, Jones RN, Schmidt, FJ, Walsh TR. Molecular characterization of a β-lactamase gene, blaGIM-1, encoding a new subclass of metallo-β-lactamase. Antimicrob Agent Chemother 2004; 48: 4654–4661
  9. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-β- lactamases: the quiet before the storm? J Clin Microbiol Rev 2005; 18: 306–325
  10. Salimi F, Eftekhar F. Coexistence of AmpC and extendedspectrum β-lactamases in metallo-β-lactamase producing Pseudomonas aeruginosa burn isolates in Tehran. Jundishapure J Microbiol 2013; 6: e7178
  11. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. Wayne, PA, USA: CLIS; 2011
  12. Thomson KS. Controversies about extended-spectrum and AmpC β-lactamases. Emerg Infect Dis 2002; 7: 333–336
  13. Lee K, Kim CK, Hong SG, Choi J, Song S, Koh E, Yong D, Jeong SH, Yum JH, Docquier JD. Characteristics of clinical isolates of Acinetobacter genomospecies 10 carrying two different metallo-β-lactamases. Int J Antimicrob Agent 2010; 36: 259– 253
  14. Yousefi S, Nahaei MR, Farajnia S, Ghojazadeh M, Akhi MT, Sharifi Y, Milani M, Ghotaslou R. Class 1 integron and imipenem resistance in clinical isolates of Pseudomonas aeruginosa: prevalence an